Open access · CC-BY
via OpenAlex
Klotho and calciprotein particles as therapeutic targets against accelerated ageing
Clinical Science · 2021 · ▲ 71 citations
Abstract
The klotho gene, named after a Greek goddess who spins the thread of life, was identified as a putative 'ageing-suppressor' gene. Klotho-deficient mice exhibit complex ageing-like phenotypes including hypogonadism, arteriosclerosis (vascular calcification), cardiac hypertrophy, osteopenia, sarcopenia, frailty, and premature death. Klotho protein functions as the obligate co-receptor for fibroblast growth factor-23 (FGF23), a bone-derived hormone that promotes urinary phosphate excretion in response to phosphate intake. Thus, Klotho-deficient mice suffer not only from accelerated ageing but also from phosphate retention due to impaired phosphate excretion. Importantly, restoration of the phosphate balance by placing Klotho-deficient mice on low phosphate diet rescued them from premature ageing, leading us to the notion that phosphate accelerates ageing. Because the extracellular fluid is super-saturated in terms of phosphate and calcium ions, an increase in the phosphate concentration can trigger precipitation of calcium-phosphate. In the blood, calcium-phosphate precipitated upon increase in the blood phosphate concentration is adsorbed by serum protein fetuin-A to form colloidal nanoparticles called calciprotein particles (CPPs). In the urine, CPPs appear in the renal tubular fluid when FGF23 increases phosphate load excreted per nephron. CPPs can induce cell damage, ectopic calcification, and inflammatory responses. CPPs in the blood can induce arteriosclerosis and non-infectious chronic inflammation, whereas CPPs in the urine can induce renal tubular damage and interstitial inflammation/fibrosis. Thus, we propose that CPPs behave like a pathogen that accelerates ageing and should be regarded as a novel therapeutic target against age-related disorders including chronic kidney disease.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1042/cs20201453
- Canonical
- link ↗
- Fetched
- 2026-11-05 MST
Cite this
APA
Kuro‐o, M. (2021). Klotho and calciprotein particles as therapeutic targets against accelerated ageing. <em>Clinical Science</em>. https://doi.org/10.1042/cs20201453
Vancouver
Kuro‐o M. Klotho and calciprotein particles as therapeutic targets against accelerated ageing. Clinical Science. 2021. doi:10.1042/cs20201453.
BibTeX
@article{makoto2021Klotho,
title = {Klotho and calciprotein particles as therapeutic targets against accelerated ageing},
author = {Makoto Kuro‐o},
journal = {Clinical Science},
year = {2021},
doi = {10.1042/cs20201453},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
PubMed 2018
Preprint
[Klotho not only antiageing protein].
The Endocrine Society's 92nd Annual Meeting, June 19–22, 2010 - San Diego 2010
Citation only
1,25-Dihydroxyvitamin D3Is a Novel Transcriptional Regulator of the Anti-Aging Gene Klotho in Human and Mouse Kidney Cells.
Genes 2023
Open access · CC-BY
The Circulating Level of Klotho Is Not Dependent upon Physical Fitness and Age-Associated Methylation Increases at the Promoter Region of the Klotho Gene
Journal of the American Society of Nephrology 2025
Citation only
Dasatinib and Quercetin Combination Increases Kidney Damage in Acute Folic Acid-Induced Experimental Nephropathy
Nature 2020
Preprint · OA
Ageing hallmarks exhibit organ-specific temporal signatures
International Journal of Molecular Sciences 2026
Open access · CC-BY